Das Gautam, Stanaway Stephen E R S, Brohan Liz
Department of Diabetes and Endocrinology, Glan Clwyd Hospital, Rhuddlan Road, Bodelwyddan, Rhyl LL18 5UJ, UK.
Case Rep Endocrinol. 2012;2012:941241. doi: 10.1155/2012/941241. Epub 2012 Mar 29.
Objective. To describe a patient with unilateral exudative pleural effusion that developed after commencement of carbimazole. Methods. We describe the presentation and clinical journey of an elderly woman who presented to the chest physicians initially with pleural effusion but was followed up by the endocrinology team. Result. The patient was a 77-year-old Caucasian woman who presented with symptoms of breathlessness and a confirmed unilateral pleural effusion while being on treatment for thyrotoxicosis. Her symptoms needed recurrent hospital admission for investigations and drainage, but no potential cause was identified after extensive investigations. A drug-induced exudative effusion consequent to carbimazole intake was diagnosed as discontinuation of the drug lead to complete resolution of the effusion with no recurrence. Conclusion. Physicians and Endocrinologist must bear in mind that this potentially rare complication of carbimazole while treating patients of thyrotoxicosis as appearance of similar features in their patients while being on carbimazole should lead to the discontinuation of the drug, and alternative treatment strategy should be considered.
目的。描述一名在开始服用卡比马唑后出现单侧渗出性胸腔积液的患者。方法。我们描述了一名老年女性的临床表现和诊疗过程,该患者最初因胸腔积液就诊于胸科医生,后由内分泌科团队进行随访。结果。患者为一名77岁的白种女性,在接受甲状腺毒症治疗期间出现呼吸困难症状,经确诊为单侧胸腔积液。她的症状需要反复住院进行检查和引流,但经过广泛检查后未发现潜在病因。诊断为服用卡比马唑导致的药物性渗出性胸腔积液,停用该药物后胸腔积液完全消退且未复发。结论。内科医生和内分泌科医生在治疗甲状腺毒症患者时必须牢记卡比马唑这种潜在的罕见并发症,因为患者在服用卡比马唑期间出现类似症状时应停用该药物,并考虑替代治疗策略。